New blood test aims to catch ovarian Cancer's return sooner
NCT ID NCT07153705
Summary
This study is testing a new blood test called OCS, which looks for tiny particles called exosomes, to see if it can detect when ovarian cancer comes back. It focuses on patients whose standard blood marker (CA125) was low when they were first diagnosed. The goal is to find a more reliable way to monitor these specific patients after their initial surgery and chemotherapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.